• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

COVID-19

BioNTechs headquarters
Biotech

BioNTech pays $200M to license OncoC4's mid-stage antibody

BioNTech is paying $200 million upfront to license OncoC4's monoclonal antibody aimed at solid tumors, furthering the former's clinical cancer work.
Max Bayer Mar 20, 2023 11:15am
An artists rendering of the BQ 11 variant of COVID-19

Immunome decides not to top up its COVID antibody cocktail

Mar 16, 2023 10:05am
Graphic images of staff members falling off a conveyor belt representing layoffs

Vaxart cans oral COVID-19 vaccine plans, lays off 27% of staff

Mar 16, 2023 6:15am
FDA stop sign

FDA defends delayed EUA for Lucira's combo COVID/flu test

Mar 13, 2023 10:13am
graphic of someone pulling a large coronavirus representative of the virus being burdensome

FDA issues first full clearance for a rapid antigen COVID test

Mar 9, 2023 11:04am
change direction new plan alter arrows move reprioritize

Invivyd evolves yet again to keep pace with COVID-19

Mar 6, 2023 10:45am
More News

Veru's EUA ambitions for its COVID treatment crash

Mar 3, 2023 11:17am

FDA issues first EUA to over-the-counter COVID and flu test

Feb 27, 2023 10:01am

'We beg you': Biotechs plead for help with long COVID research

Feb 22, 2023 11:20am

Medtronic slows sales slip with flat revenues in Q3

Feb 21, 2023 3:05pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy